“Production of Lentivirus Particles Pseudotyped With SARS-CoV-2 Spike Protein for Neutralisation or Drug Antiviral Activity Assays”. One Health & Risk Management , Dec. 2023, p. 77, https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/657.